Ind-Swift Laboratories Limited
NSE: INDSWFTLAB.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Navrattan R. Munjal
- Employees
- 47
- Headquarters
- Manimajra, India
- IPO year
- 2002
- Market cap
- ₹12.0B
- Website
- https://www.indswiftlabs.com
Loading INDSWFTLAB…
Loading profile data…Frequently asked questions about INDSWFTLAB
What does Ind-Swift Laboratories Limited (INDSWFTLAB.NS) do?
Ind-Swift Laboratories Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, antimigraine, Parkinson disease, hyperparathyrodism, anal...
Where does INDSWFTLAB.NS trade?
Ind-Swift Laboratories Limited (INDSWFTLAB.NS) trades on the National Stock Exchange of India.
What sector is INDSWFTLAB.NS in?
Ind-Swift Laboratories Limited (INDSWFTLAB.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Ind-Swift Laboratories Limited?
Navrattan R. Munjal is the chief executive officer of Ind-Swift Laboratories Limited (INDSWFTLAB.NS).
Where is Ind-Swift Laboratories Limited headquartered?
Ind-Swift Laboratories Limited is headquartered in India.
Does INDSWFTLAB.NS pay a dividend?
Ind-Swift Laboratories Limited (INDSWFTLAB.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did INDSWFTLAB.NS go public?
Ind-Swift Laboratories Limited (INDSWFTLAB.NS) completed its initial public offering in 2002.